With this Investigation, we aimed to assess the effect of PDUFA legislation past the person rate method itself, by pinpointing all provisions of PDUFA regulations that made variations to FDA regulatory policy or even the agency’s interactions with the controlled market. Two authors reviewed the full texts of all enacted PDUFA reauthorization guid